Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06211517

Drugs Experience for Adolescents With Anorexia

The purpose of this study is to access to the experiences of adolescents, their parents and healthcare professionals regarding psychotropic drugs in anorexia nervosa.

No preconceived ideas (according to qualitative methods) but a question: what are the participants' perceptions and experiences of psychotropic drugs in anorexia nervosa? In an adolescent medicine department.

Recruiting

Interested in participating?

Request Info

Key information

Age range

12 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

About this study

Psychotropic prescription is common to adolescents suffering from anorexia nervosa. A first qualitative study (E3A Protocol "Experience of adolescents with anorexia nervosa toward antidepressants") looked at the experience of antidepressants among 15 adolescents suffering from anorexia nervosa. Analysis of the interviews identified two meta-themes:

  • Reactions to the proposal of antidepressant with an opposition phase (about the existence of depressive symptoms and about negative preconceptions) and need to share with family and other teenagers.
  • Reactions to antidepressant use with ambivalence and an initial perception of coercion, and effects of antidepressants (psychological effects, effects on the body and on anorexia nervosa and effects perceived through the eyes of others).

Nine adolescents (out of 15) were also taking an atypical antipsychotic (APA) often prescribed in case of anorexia nervosa resistance.

The need to share with family about the proposal of antidepressant and the effects perceived through the eyes of others (including parent's eyes) lead us to take an interest in parents perceptions.

Two decisive periods were identified: What do healthcare professionals think about psychotropic treatments for anorexia nervosa in adolescence? How do they propose treatment?

Interviewing teenagers, their parents as well as healthcare professionals, will enable to access to the complexity of representations and experiences of these psychotropic drugs in anorexia nervosa.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Adolescents :

  • Aged 12 to 25 years
  • Suffering from anorexia nervosa (restrictive or mixed) according to DSM-5 (Diagnostic and Statistical Manual) criteria
  • Received psychotropic drugs (antidepressant treatment and/or APA) during their care, either ongoing or discontinued before this study started

Parents of adolescents suffering from anorexia nervosa for whom a psychotropic drug has been prescribed and whose adolescents meet inclusion criteria

Healthcare Professionals working with adolescents suffering from eating disorders

Exclusion criteria

Adolescents :

  • Atypical eating disorder that does not meet the DSM-5 criteria for restrictive or mixed anorexia nervosa
  • BMI<15
  • Prescription of an antidepressant other than an SSRI (Selective Serotonin Reuptake Inhibitor)
  • Prescription of an APA for the indication of psychotic symptoms

Treatment and study plan

Semi-structured interviews with visual mediations

Other

Semi-structured interviews with visual mediations / An hour-long interview

Other names: Qualitative interviews

semi-structured interviews

Other

Semi-structured interviews

Other names: Qualitative interviews

Primary outcomes

  1. Semi-structured interview

    Time frame: Day of inclusion

    Themes describing adolescent experiences regarding psychotropic drugs in anorexia nervosa - Emergence of themes describing participants' experience from analysis of qualitative interviews (with Interpretative Phenomenology Analysis methodology)

Secondary outcomes

  1. Semi-structured interview

    Time frame: Day of inclusion

    Themes describing parents experiences regarding psychotropic drugs for their children suffering from anorexia nervosa - Emergence of themes describing participants' experience from analysis of qualitative interviews (with Interpretative Phenomenology Analysis methodology)

  2. Semi-structured interview

    Time frame: Day of inclusion

    Themes describing healthcare professionals experiences regarding psychotropic drugs for adolescents suffering from anorexia nervosa - Emergence of themes describing participants' experience from analysis of qualitative interviews (with Interpretative Phenomenology Analysis methodology)

Study contacts

Contact information is provided by the study sponsor or research team.

Marie Benhammani-Godard

CONTACT

[email protected]

00 33 1 58 41 11 90

Maude Ludot-Gregoire, MD, psychiatrist

CONTACT

[email protected]

00 33 1 58 41 28 41

Sponsors and collaborators

Lead sponsor

Assistance Publique - Hôpitaux de Paris

Other

Collaborators

  • URC-CIC Paris Descartes Necker Cochin

Registry information

Official study title

Subjective Experience of Psychotropic Drugs Among Adolescents (Their Parents and Professionals) With Anorexia Nervosa

Acronym: E3P

Important dates

Study start
2024
Primary completion
2027
Study completion
2027
First posted
Jan 18, 2024
Registry last updated
Sep 12, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.